Register to view the archived recording here.
Illumina Obtains More Than 55 Gb from GA; Expects Large NIH Stimulus Awards for Sequencing
The company reported $162 million in total revenue for the second quarter, a 15 percent increase over the prior-year quarter that company officials attributed to "significant" growth in sales of sequencing products.
New to GenomeWeb? Register here quickly.